Summary
McKesson HBOC, Inc. (MCK) announced significant leadership changes and a strategic restructuring of its iMcKesson business unit. Effective April 1, 2001, John H. Hammergren, currently co-CEO and CEO of McKesson HBOC, will assume the role of President and CEO. This transition marks a shift in leadership as David Mahoney, the other co-CEO and CEO of iMcKesson, will depart from the company and its Board of Directors. The company is also undertaking a restructuring of its iMcKesson business unit. Physician offerings and transaction hub functions will be integrated into the Information Technology Business. Simultaneously, the medical management business will operate as a distinct standalone unit, reporting financially within the Supply Management Business. These changes indicate a strategic realignment aimed at optimizing operations and focusing on core business segments.
Key Highlights
- 1John H. Hammergren to become President and CEO of McKesson HBOC, Inc. effective April 1, 2001.
- 2Current co-CEO David Mahoney to depart the company and resign from the Board of Directors.
- 3Restructuring of the iMcKesson business unit announced.
- 4Physician offerings and transaction hub to be moved into the Information Technology Business.
- 5Medical management business to become a standalone unit, reporting within the Supply Management Business.
- 6The press release detailing these changes is attached as Exhibit 99.1.